Minnesota HF5156: Price for prescription drugs subject to the Medicare Drug Price Negotiation Program established.

What the bill says

A bill for an act relating to health care; establishing prices for prescription drugs subject to the Medicare Drug Price Negotiation Program; proposing coding for new law in Minnesota Statutes, chapter 62Q.

From the introduced text, May 16, 2026:

A bill for an act relating to health care; establishing prices for prescription drugs subject to the Medicare Drug Price Negotiation Program; proposing coding for new law in Minnesota Statutes, chapter 62Q. Section 1. new text begin [ADDED: [62Q.586] MAXIMUM FAIR PRICE FOR CERTAIN PRESCRIPTION DRUGS.] new text end new text begin [ADDED: Subdivision 1.] new text end new text begin [ADDED: Definitions.] new text end new text begin [ADDED: (a) For purposes of this section, the following terms have the meanings given.] new text end new text begin [ADDED: (b) "Manufacturer" has the meaning given in section 151.01, subdivision 14a.] new text end new text begin [ADDED: (c) "Maximum fair price" means the maximum fair price established for a prescription drug by the United States Department of Health and Human Services under United States Code, title 42, section 1320f-3.] new text end new text begin [ADDED: (d) "NADAC" means the national average drug acquisition cost.] new text end new text begin [ADDED: (e) "Pharmacy benefit manager" means a pharmacy benefit manager licensed under chapter 62W.] new text end new text begin [ADDED: (f) "Referenced drug" means a prescription drug subject to a maximum fair price.] new text end new text begin [ADDED: Subd. 2.] new text end new text begin [ADDED: Maximum fair price requirements.] new text end new …

Read the full official text

Sponsors

• Michael Howard (D) · primary sponsor
• Leigh Finke (D)
• Steve Elkins (D)
• Anquam Mahamoud (D)
• Ethan Cha (D)
• Liz Reyer (D)
• Kristin Bahner (D)
• Brad Tabke (D)
• Matt Norris (D)
• Lucy Rehm (D, 48B)
• Kari Rehrauer (D)
• Kaela Berg (D)

Latest actions

1. May 17, 2026: Authors added Berg; Kozlowski; Pursell; Jordan; Kraft; Johnson, P.; Freiberg; Virnig; Liebling; Gottfried; Youakim; Greenman; Feist; and Falconer
2. May 17, 2026: Introduction and first reading, referred to Health Finance and Policy

Common questions

What is HF5156?

HF5156 is a bill in the Minnesota Legislature (94th Legislature 2025-2026): Price for prescription drugs subject to the Medicare Drug Price Negotiation Program established.

What does HF5156 do?

In its own words: A bill for an act relating to health care; establishing prices for prescription drugs subject to the Medicare Drug Price Negotiation Program; proposing coding for new law in Minnesota Statutes, chapter 62Q.

What is the status of HF5156?

In committee as of May 17, 2026. Latest action: Authors added Berg; Kozlowski; Pursell; Jordan; Kraft; Johnson, P.; Freiberg; Virnig; Liebling; Gottfried; Youakim; Greenman; Feist; and Falconer (May 17, 2026).

Who sponsored HF5156?

Michael Howard (D), with 11 co-sponsors.

Where is the official record for HF5156?

On the Minnesota Legislature website: https://www.revisor.mn.gov/bills/bill.php?f=HF5156&y=2025&ssn=0&b=house